ALBPS Biophytis S.A.

0.0364USD0.0332 EUR · EPA+7.10%Mkt Cap: 13.55M USDP/E: —

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company'…

Key Statistics

Company
Market Cap13.55M USD
Enterprise Value7.92M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-8.81M USD
Revenue/Share—
Last Price0.0364 USD
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees19
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR001400OLP5
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-0.92
EV/Revenue—
P/S—
P/B-0.10
EPS (TTM)-0.37 USD
EPS (Forward)-2.36 USD
52W Range
0.004619% of range0.1700
52W High0.1700 USD
52W Low0.0046 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-66.56%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.48M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-13.24%
Net Debt7.14M USD
Net Debt/EBITDA-0.83
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.68
Current Ratio0.35
Quick Ratio0.33
Book Value/Sh-0.37 USD
Cash/Share0.06 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:400
Split DateMay 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.389.86M
Float23.36M
Insiders0.45%
Institutions0.47%
Technical
SMA 500.0467 (-22.0%)
SMA 2000.0383 (-4.9%)
Beta1.84
S&P 52W Chg12.00%
Avg Vol (30d)24.02M
Avg Vol (10d)36.49M
Technical Indicators
RSI (14)42.5
MACD-0.0021
MACD Signal-0.0020
MACD Hist.-0.0001
BB Upper0.0500 USD
BB Middle0.0391 USD
BB Lower0.0283 USD
BB Width55.43%
ATR (14)0.0064 USD
Vol Ratio (20d)0.55x

About Biophytis (EPA: ALBPS)

›

Biophytis (EPA: ALBPS) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 19 employees.

The shares were at 0.0332 EUR on 19 November 2026, down 58.4% over 52 weeks. Its 52-week range is 0.0042 EUR to 0.1550 EUR: the price is 78.6% below the high and 690.5% above the low.

Its market capitalisation is 12.36M EUR.

Biophytis reports an operating margin of 0.0%.

Its debt exceeds its cash by 6.51M EUR. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health.